Abstract
Veterinary vaccines must be authorised by the relevant competent authorities in the EU. An application for a Marketing Authorisation (MA) must be submitted and this should include a dossier that demonstrates the quality of the vaccine and the safety and efficacy in the target species. It should be noted that safety must also be demonstrated for the user, the environment and the consumer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code relating to veterinary medicinal products. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2001:311:0001:0066:en:pdf (2001)
Directive 2004/28/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/82/EC on the Community Code relating to veterinary medicinal products. http://ec.europa.eu/health/files/eudralex/vol-5/dir_2004_28/dir_2004_28_en.pdf (2004)
Commission Directive 2009/9/EC of 10 February 2009 amending Directive 2001/82/EC of the European Parliament and of the Council on the Community code relating to medicinal products for veterinary use. Official Journal L 44, 14/2/2009. p. 10–61. http://ec.europa.eu/health/files/eudralex/vol-5/dir_2009_9/dir_2009_9_en.pdf (2009)
Consolidated Directive 2001/82/EC as amended by Directive 2004/28/EC of the European Parliament and of the Council of 31 March 2004, Directive 2009/9/EC of 10 February 2009, Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009, Directive 2009/53/EC of the European Parliament and of the Council of 18 June 2009 and Regulation (EC) No 596/2009 of the European Parliament and of the Council of 18 June 2009 http://ec.europa.eu/health/files/eudralex/vol-5/dir_2001_82_cons2009/dir_2001_82_cons2009_en.pdf (2009)
EudraLex – Volume 6 notice to applicants and regulatory guidelines for medicinal products for veterinary use. Volume 6A procedures for marketing authorisation. http://ec.europa.eu/health/files/eudralex/vol-6/a/vol6a_chap1_2007-01_en.pdf (2007)
EudraLex – Volume 6 notice to applicants and regulatory guidelines for medicinal products for veterinary use. Volume 6A procedures for marketing authorisation chapter 4 centralised procedure. http://ec.europa.eu/health/files/eudralex/vol-6/a/vol6a_chap4_2006_05_en.pdf (2006)
Commission Directive 91/412/EEC of 23 July 1991 laying down the principles and guidelines of good manufacturing practice for veterinary medicinal products http://ec.europa.eu/health/files/eudralex/vol-5/dir_1991_412/dir_1991_412_en.pdf (1991)
Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:136:0001:0033:EN:PDF (2004)
Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the environment of genetically modified organisms and repealing Council Directive 90/220/EEC. http://ec.europa.eu/health/files/eudralex/vol-1/dir_2001_18/dir_2001_18_en.pdf (2001)
European Medicines Agency: Veterinary presubmission Q & A for innovative products. http://www.emea.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000171.jsp&mid=WC0b01ac058002d9ab (2012)
European Medicines Agency: EMA/CVMP/172329/2004-Rev.3. Guidance for companies requesting scientific advice. http://www.emea.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/10/WC500004147.pdf (2012)
EudraLex – Volume 6 notice to applicants and regulatory guidelines for medicinal products for veterinary use. Volume 6C regulatory guidelines. Summary of the product characteristics SPC – immunologicals. http://ec.europa.eu/health/files/eudralex/vol-6/c/spc_immunologicals_rev3_08-06-2007_en.pdf (2007)
European Medicines Agency: EMA/1531641/2010. Pre-submission instruction on the detailed description of the pharmacovigilance system of a marketing authorisation holder; to be submitted with a marketing authorisation application for a veterinary medicinal product http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2012/03/WC500123503.pdf (2012)
European Medicines Agency: EMA/CVMP/IWP/123243/2006-Rev.2. Guideline on Data requirements for Immunological veterinary medicinal products intended for minor use or minor species/limited markets. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/04/WC500089628.pdf (2010)
Regulation (EC) No 2049/2005 of 15 December 2005 laying down, pursuant to Regulation (EC) No 726/2004 of the European Parliament and of the Council, rules regarding the payment of fees to, and the receipt of administrative assistance from, the European Medicines Agency by micro, small and medium-sized enterprises. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2005:329:0004:0007:EN:PDF (2005)
European Medicines Agency: EMA/204919/2010 user guide for micro, small and medium-sized enterprises (SMEs) http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/10/WC500004134.pdf (2010)
European Medicines Agency: EMA/613295/2011-Rev.1. Electronic submission of veterinary dossiers questions and answers. http://www.emea.europa.eu/docs/en_GB/document_library/Other/2012/05/WC500127591.pdf (2012)
European Pharmacopoeia 7th Ed. Vaccines for veterinary use. Monograph 04/2013: 0062. European Pharmacopoeia, Strasbourg, France. (2013)
European Pharmacopoeia 7th Ed. Evaluation of safety of veterinary vaccines and immunosera Monograph 04/2013:50206. European Pharmacopoeia, Strasbourg, France. (2013)
European Pharmacopoeia 7th Ed. Evaluation of efficacy of veterinary vaccines and immunosera. Monograph 04/2008:50207. (2013)
European Pharmacopoeia 7th Ed. Pasteurella vaccine (inactivated) for sheep. Monograph 04/2013:2072. (2013)
European Medicines Agency: EMA/CVMP/IWP/206555/2010. Guideline on requirements for the production and control of immunological veterinary medicinal products. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500128997.pdf (2012)
European Medicines Agency: Immunologicals guidelines. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000194.jsp&mid=WC0b01ac058002dd33 (2012)
European Medicines Agency. SOP/V/4012. Evaluation of veterinary medicinal products containing or consisting of Genetically Modified Organisms. http://www.ema.europa.eu/docs/en_GB/document_library/Standard_Operating_Procedure_-_SOP/2009/09/WC500003079.pdf (2012)
European Medicines Agency: Immunologicals guidelines. http://www.emea.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000194.jsp&mid=WC0b01ac058002dd33 (2012)
VICH Topic GL41. EMEA/CVMP/VICH/1052/2004. Guideline on target animal safety: examination of live veterinary vaccines in target animals for absence of reversion to virulence. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004552.pdf (2007)
VICH Topic GL44 Step 7. EMEA/CVMP/VICH/359665/2005. Guideline on target animal safety for veterinary live and inactivated vaccines. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004553.pdf (2008)
European Medicines Agency: EMA/CVMP/IWP/594618/2010 draft. Guideline on the requirements for combined vaccines and associations of immunological veterinary medicinal products (IVMPs). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/11/WC500118227.pdf (2011)
European Medicines Agency:. EMA/CVMP/IWP/439467/2007 Reflection paper on the demonstration of a possible impact of maternally derived antibodies on vaccine efficacy in young animals. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/03/WC500076626.pdf (2010)
Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council. http://ec.europa.eu/health/files/eudralex/vol-5/reg_2009-470/reg_470_2009_en.pdf (2009)
European Medicines Agency: EMA/CVMP/519714/2009-Rev.12 Substances considered as not falling within the scope of Regulation (EC) No 470/2009, with regards to residues of veterinary medicinal products in foodstuffs of animal origin. http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/10/WC500004958.pdf (2012)
European Medicines Agency: EMA/CVMP/516817/2009 Guideline on data to be provided in support of a request to include a substance in the list of substances considered as not falling within the scope of Regulation (EC) No 470/2009. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/11/WC500099149.pdf (2010)
European Pharmacopoeia 7th Ed. Neonatal piglet colibacillosis vaccine (inactivated). Monograph 04/2013:0962. (2013)
European Medicines Agency: EMA/CVMP/IWP/314550/2010 Guideline on the design of studies to evaluate the safety and efficacy of fish vaccines. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/11/WC500118226.pdf (2011)
Heads of Medicine Agency: Veterinary medicines. http://www.hma.eu/veterinary.html (2012)
European Medicines Agency: EMEA/CVMP/248499/2007 recommendation on the evaluation of the benefit-risk balance of veterinary medicinal products. http://www.ema.europa.eu/docs/en_GB/document_library/Other/2009/10/WC500005264.pdf (2009)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Banks, R. (2014). Veterinary Vaccines: EU Regulatory Requirements. In: Giese, M. (eds) Molecular Vaccines. Springer, Cham. https://doi.org/10.1007/978-3-319-00978-0_30
Download citation
DOI: https://doi.org/10.1007/978-3-319-00978-0_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-00977-3
Online ISBN: 978-3-319-00978-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)